Swedish medical technology company Mölnlycke Health Care has started construction on the expansion of its $135m wound care manufacturing facility in Brunswick, Maine, US.
The facility expansion aims to enhance the company’s production capacity in the US.
It will incorporate renewable energy solutions, such as wind and solar power, to meet Mölnlycke’s sustainability targets.
Additionally, the plant will feature advanced machinery from suppliers in the US.
Over the coming five years, the expansion is expected to boost employment in Maine by approximately 10% and involve local contractors and suppliers.
Mölnlycke said the move aligns with its strategy to localise manufacturing and address the increasing demand from US healthcare providers.
Mölnlycke CEO Zlatko Rihter said: “This expansion is a bold step forward for Mölnlycke in the US.
“It reinforces our mission to free patients and caregivers from the burden of wounds, strengthens supply resilience, and helps us to deliver high-quality wound care solutions faster, smarter, and more sustainably.”
The project was kicked off with a groundbreaking ceremony attended by key political figures, including US Senator Angus King and Maine governor Janet Mills.
Mölnlycke aims to improve the accessibility of its advanced wound care products for US patients through this development.
“Today isn’t just about breaking ground. It’s about being bold, embracing partnerships and leading with passion,” said Chris Biddle, general manager for Mölnlycke’s US wound care production.
“Thank you to everyone who helped bring this vision to reality. The expansion is a win for Mölnlycke, for the local community and, ultimately, for the patients we serve.”
Earlier this year, the company signed a $400m financing agreement with the Swedish Export Credit Corporation (SEK) to support its growth and development.
The ten-year arrangement aims to underpin the company’s global growth and strategic initiatives.
“Mölnlycke Health Care begins $135m US wound care facility expansion” was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.